SYRE filings
Corporate insider profile
Jeffrey W. Albers Filing Activity
Latest reported as Corporate insider of Spyre Therapeutics, Inc. (SYRE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,404,190.00
- Latest transaction
- Aug 7, 2026
Affiliated corporations
Reported company relationships
Transaction history
